🔗 Permalink

Inventor profile of:

Michael Christopher Scaife

City:

Los Altos, California

Country:

United States

Published Applications:

Last publication date:

2019-06-27

Top Assignees for applications by Michael Christopher Scaife

The entities that hold a legal rights for patent applications filed by inventor Scaife Michael Christopher:

The Regents of the University of California 28 Oakland, CA United States
Otonomy, Inc. 28 San Diego, CA United States
The Regents of the Univeristy of California 1 Oakland, CA United States

Recent patent applications by Scaife Michael Christopher

Michael Christopher Scaife from Los Altos, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-06-27

US20190192425A1

Human necessities

CONTROLLED RELEASE DELIVERY DEVICES FOR THE TREATMENT OF OTIC DISORDERS

#2 | 2018-04-26

US20180110727A1

Human necessities

CONTROLLED RELEASE CORTICOSTEROID COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#3 | 2017-01-05

US20170000728A1

Human necessities

Controlled-Release CNS Modulating Compositions and Methods for the Treatment of Otic Disorders

#4 | 2016-10-27

US20160310415A1

Human necessities

CONTROLLED RELEASE COMPOSITIONS FOR MODULATING FREE-RADICAL INDUCED DAMAGE AND METHODS OF USE THEREOF

#5 | 2016-08-25

US20160243028A1

Human necessities

Auris formulations for treating otic diseases and conditions

#6 | 2016-08-11

US20160228357A1

Human necessities

Auris Formulations for Treating Otic Diseases and Conditions

#7 | 2016-07-14

US20160199446A1

Human necessities

CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#8 | 2016-04-07

US20160095902A1

Human necessities

Auris formulations for treating otic diseases and conditions

#9 | 2016-02-11

US20160038491A1

Human necessities

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

#10 | 2015-11-05

US20150313838A1

Human necessities

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#11 | 2014-12-11

US20140364510A1

Human necessities

Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders

#12 | 2014-12-11

US20140364403A1

Human necessities

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#13 | 2014-10-16

US20140309217A1

Human necessities

Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

#14 | 2014-08-28

US20140243425A1

Human necessities

Controlled release compositions for modulating free-radical induced damage and methods of use thereof

#15 | 2014-01-16

US20140018395A1

Human necessities

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

#16 | 2013-06-13

US20130150410A1

Human necessities

Controlled Release Ion Channel Modulator Compositions and Methods for the Treatment of Otic Disorders

#17 | 2012-07-26

US20120190671A1

Human necessities

Controlled-release CNS modulating compositions and methods for the treatment of otic disorders

#18 | 2011-12-29

US20110319377A1

Human necessities

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#19 | 2011-12-29

US20110319375A1

Human necessities

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#20 | 2011-12-29

US20110319374A1

Human necessities

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#21 | 2011-12-29

US20110319373A1

Human necessities

Controlled release corticosteroid compositions and methods for the treatment of otic disorders

#22 | 2010-02-11

US20100036000A1

Human necessities

Controlled release antimicrobial compositions and methods for the treatment of otic disorders

#23 | 2010-01-28

US20100022661A1

Human necessities

Controlled release compositions for modulating free-radical induced damage and methods of use thereof

#24 | 2010-01-28

US20100021416A1

Human necessities

Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders

#25 | 2010-01-21

US20100016450A1

Human necessities

CONTROLLED RELEASE DELIVERY DEVICES FOR THE TREATMENT OF OTIC DISORDERS

#26 | 2010-01-21

US20100016218A1

Human necessities

CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#27 | 2010-01-21

US20100015263A1

Human necessities

Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

#28 | 2010-01-21

US20100015228A1

Human necessities

Controlled release ion channel modulator compositions and methods for the treatment of otic disorders

#29 | 2010-01-14

US20100009952A1

Human necessities

Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders

#30 | 2010-01-07

US20100004225A1

Human necessities

Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders

#31 | 2009-12-31

US20090325938A1

Human necessities

CONTROLLED-RELEASE CNS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS

#32 | 2009-12-31

US20090324552A1

Human necessities

Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders

#33 | 2009-12-10

US20090306225A1

Human necessities

Auris formulations for treating otic diseases and conditions

#34 | 2009-12-03

US20090297533A1

Chemistry; metallurgy

Controlled release immunomodulator compositions and methods for the treatment of otic disorders

InventorID:

287973 ⎘